Cell Reports Publication on the Mechanism of Action of NOXXON's Anti-SDF-1 Spiegelmer® Olaptesed Pegol (NOX-A12) in Preclinical Multiple Myeloma Models
NOXXON Pharma announced today the publication of a new study in Cell Reports, entitled "SDF-1 Inhibition Targets the Bon…